Integrated BioPharma, Inc. (INBP)
0.167
-0.01
(-7.22%)
USD |
OTCM |
Aug 24, 16:00
Integrated BioPharma Enterprise Value : 2.707M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.707M |
| August 21, 2026 | 3.111M |
| August 20, 2026 | 3.050M |
| August 19, 2026 | 3.050M |
| August 18, 2026 | 3.088M |
| August 17, 2026 | 2.490M |
| August 14, 2026 | 2.736M |
| August 13, 2026 | 2.502M |
| August 12, 2026 | 2.499M |
| August 11, 2026 | 2.499M |
| August 10, 2026 | 2.499M |
| August 07, 2026 | 2.499M |
| August 06, 2026 | 2.200M |
| August 05, 2026 | 2.496M |
| August 04, 2026 | 2.496M |
| August 03, 2026 | 2.496M |
| July 31, 2026 | 2.496M |
| July 30, 2026 | 2.490M |
| July 29, 2026 | 2.490M |
| July 28, 2026 | 2.184M |
| July 27, 2026 | 2.493M |
| July 24, 2026 | 2.493M |
| July 23, 2026 | 2.493M |
| July 22, 2026 | 2.615M |
| July 21, 2026 | 2.491M |
| Date | Value |
|---|---|
| July 20, 2026 | 2.491M |
| July 17, 2026 | 2.497M |
| July 16, 2026 | 2.645M |
| July 15, 2026 | 2.644M |
| July 14, 2026 | 2.583M |
| July 13, 2026 | 2.634M |
| July 10, 2026 | 2.634M |
| July 09, 2026 | 2.634M |
| July 08, 2026 | 2.634M |
| July 07, 2026 | 2.803M |
| July 06, 2026 | 2.552M |
| July 02, 2026 | 3.101M |
| July 01, 2026 | 3.101M |
| June 30, 2026 | 3.101M |
| June 29, 2026 | 3.101M |
| June 26, 2026 | 3.101M |
| June 25, 2026 | 3.101M |
| June 24, 2026 | 3.101M |
| June 23, 2026 | 3.111M |
| June 22, 2026 | 3.421M |
| June 18, 2026 | 3.387M |
| June 17, 2026 | 3.387M |
| June 16, 2026 | 3.387M |
| June 15, 2026 | 3.387M |
| June 12, 2026 | 3.134M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medifast, Inc. | -8.031M |
| BioForce Nanosciences Holdings, Inc. | 130.84M |
| Skinvisible, Inc. | 6.832M |
| Nevis Brands, Inc. | 0.8626M |
| Skinhealth Systems, Inc. | 249.44M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.837M |
| Revenue (Quarterly) | 10.11M |
| Total Expenses (Quarterly) | 10.94M |
| EPS Diluted (Quarterly) | -0.027 |
| Gross Profit Margin (Quarterly) | -2.73% |
| Profit Margin (Quarterly) | -8.28% |
| Earnings Yield | -31.98% |
| Normalized Earnings Yield | -31.98 |